These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14598486)

  • 1. [A differentiated approach to the treatment of normal-pressure glaucoma].
    Grigor'eva EG
    Vestn Oftalmol; 2003; 119(5):14-6. PubMed ID: 14598486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glaucoma: an ocular blood flow disorder?].
    Recker K
    Ophthalmologe; 2003 Feb; 100(2):2 p following 174. PubMed ID: 12650170
    [No Abstract]   [Full Text] [Related]  

  • 3. Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study.
    Rossi GC; Tinelli C; Pasinetti GM; Fusetti M; Pallavicini C; Stringa M; Vacchi S; Stringa F; Bianchi PE
    Expert Opin Pharmacother; 2011 Apr; 12(5):685-90. PubMed ID: 21385109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does glaucoma medication influence the diameter of the retinal arteriole in the human eye? (A pilot study using the retinal vessel analyser).
    Kóthy P; Holló G
    Acta Physiol Hung; 2001; 88(3-4):281-92. PubMed ID: 12162586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined therapy in glaucoma treatment: travoprost 0.004% and brinzolamid].
    Popović Suić S; Vukojević N; Cerovski B; Jukić T
    Acta Med Croatica; 2006; 60(2):101-3. PubMed ID: 16848197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
    Liu JH; Medeiros FA; Slight JR; Weinreb RN
    Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic difficulties in neovascular glaucoma].
    Macarie S; Palko Z
    Oftalmologia; 2006; 50(2):73-6. PubMed ID: 16927763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic antihypertensive medication and incident open-angle glaucoma.
    Müskens RP; de Voogd S; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
    Ophthalmology; 2007 Dec; 114(12):2221-6. PubMed ID: 17568677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs and glaucoma.
    Soll DB; Saxon AM
    Am Fam Physician; 1986 Jul; 34(1):181-5. PubMed ID: 2873739
    [No Abstract]   [Full Text] [Related]  

  • 12. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
    Holló G; Kóthy P
    Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
    Kaback M; Scoper SV; Arzeno G; James JE; Hua SY; Salem C; Dickerson JE; Landry TA; Bergamini MV;
    Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology aspects of glaucoma].
    Alm A; Berggren L
    Nord Med; 1992; 107(12):306-8, 318. PubMed ID: 1361228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
    Holló G; Bozkurt B; Irkec M
    Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The evaluation of the efficacy of treatment in glaucoma associated with Sturge-Weber syndrome].
    Oziebło-Kupczyk M; Urban B; Mrugacz M; Bakunowicz-Lazarczyk A
    Klin Oczna; 2007; 109(1-3):46-8. PubMed ID: 17687912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].
    Nenciu A; Stefan C; Ardelean C
    Oftalmologia; 2004; 48(1):35-42. PubMed ID: 15279417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.